DCF — RUTLAND REGIONAL MEDICAL CENTER
Enterprise Value: $-604.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-604.3M
Enterprise Value
$-189.0M
PV of Cash Flows
$-415.2M
PV of Terminal Value
$-668.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $314.5M | $-38.8M | -12.0% | $-52.1M | $-47.4M |
| Year 2 | $324.0M | $-36.7M | -11.0% | $-50.4M | $-41.7M |
| Year 3 | $333.7M | $-34.5M | -10.0% | $-48.6M | $-36.5M |
| Year 4 | $343.7M | $-33.8M | -10.0% | $-48.4M | $-33.0M |
| Year 5 | $354.0M | $-33.9M | -10.0% | $-48.9M | $-30.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-604.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$305.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12839539172536346
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5